Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Bristol Featured PhD Programmes
Swansea University Featured PhD Programmes
University of Hong Kong Featured PhD Programmes
University of Kent Featured PhD Programmes
Max Planck Society Featured PhD Programmes
"cancer research uk"×
10 miles

"cancer research uk" PhD Projects, Programs & Scholarships

We have 15 "cancer research uk" PhD Projects, Programs & Scholarships

  • "cancer research uk" ×
  • clear all
Order by 
Showing 1 to 10 of 15
  Wellcome 4-year PhD Programme in Developmental Mechanisms
4-year PhD Programme in Developmental Mechanisms. 5 Studentships Starting October 2019. Application Deadline 3 January 2019. Interviews to be held 21/22 January 2019.
  MRC DiMeN Doctoral Training Partnership: Antiretroviral-induced metabolic toxicity: Role of adipose- miRNAs as mechanistic regulators and toxicity biomarkers
  Dr S Pushpakom
Application Deadline: 21 January 2019
Supervisors. Dr S Pushpakom. Prof M Bushell. Prof Sir M Pirmohamed. Background. Diabetes, obesity and cardiovascular disease (collectively called cardiometabolic disease) remain a major public health problem worldwide.
  Can we predict cancer cell migration and spread using deep and machine learning of pathology images?
  Prof R H Insall, Dr J Edwards
Application Deadline: 11 January 2019
The Cancer Research UK Beatson Institute in Glasgow is one of the world leading centres for cancer research. The Institute provides an outstanding research environment, underpinned by state-of-the-art core services and advanced technologies with special emphasis on imaging, metabolomics and in vivo models of cancer.
  Defining targets modulating anti-tumour immune effectors in vivo
  Dr E Roberts
Application Deadline: 11 January 2019
The Cancer Research UK Beatson Institute in Glasgow is one of the world-leading centres for cancer research. The Institute provides an outstanding research environment, underpinned by state-of-the-art core services and advanced technologies with special emphasis on imaging, metabolomics and in vivo models of cancer.
  Exploiting metabolic vulnerability in cancer
  Dr D Lewis
Application Deadline: 11 January 2019
The Cancer Research UK Beatson Institute in Glasgow is one of the world leading centres for cancer metabolism research.
  Regulation of immune cell localisation in cancer pathogenesis
  Dr L Carlin
Application Deadline: 11 January 2019
The Cancer Research UK Beatson Institute in Glasgow is one of the world-leading centres for cancer research. The Institute provides an outstanding research environment, underpinned by state-of-the-art core services and advanced technologies with special emphasis on imaging, metabolomics and in vivo models of cancer.
  PhD studentship - Pre-clinical models to study the immune - oncology of hepatocellular carcinoma
  Dr H Reeves
Application Deadline: 31 December 2018
Number of awards. 1. Start date and duration. March 2019 for 4 years. Overview. This studentship is funded as part of the CRUK/ FC AECC/ IARC Accelerator awarded ‘HUNTER.
  MRC Precision Medicine DTP: Trascriptome-wide association analysis of survival in colorectal cancer patients
  Prof M Dunlop, Dr E Theodoratou, Dr M Timofeeva
Application Deadline: 7 January 2019
Background. Colorectal cancer (CRC) is the second most common cause of cancer death in UK with 15,900 CRC deaths in 2014. The risk of recurrence and death depends very much on the stage of disease at the time of diagnosis with 5-year survival rate >90% for stage I and.
  Detecting Pancreatic Cancer in Individuals with New-Onset Diabetes Mellitus
  Prof E Costello, Prof W Greenhaf
Application Deadline: 15 December 2018
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal common cancer (five-year survival is 5-7%). For ~80% of patients, PDAC is detected after disease spread, limiting treatment options.
  Enhancing Radiotherapy Outcomes for Oesophageal Cancer
  Dr M Hawkins, Prof F Van den Heuvel
Application Deadline: 11 January 2019
Inhibition of ATR (a DNA damage checkpoint kinase) is currently being evaluated with radiotherapy and chemoradiation in patients with oesophageal cancer in the Cancer Research UK/MRC funded CHARIOT clinical study, whilst dose escalation is being evaluated in the SCOPE 2 clinical study.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.